Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

SEN virus. A clinical review.

E M Yoshida1, S G M Wong

  • 1Department of Medicine, University of British Columbia, British Columbia Transplant Society, Vancouver, BC, Canada.

Minerva Gastroenterologica E Dietologica
|February 21, 2006
PubMed
Summary

Seneca Valley Virus (SEN-V), a DNA virus, is globally distributed and transmitted through blood. While initially linked to hepatitis, most infected individuals do not develop liver disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stereotactic Body Radiotherapy for Large Unresectable Hepatocellular Carcinomas - A Single Institution Phase II Study.

Clinical oncology (Royal College of Radiologists (Great Britain))·2020
Same author

"Another thing to live for": Supporting HCV treatment and cure among Indigenous people impacted by substance use in Canadian cities.

The International journal on drug policy·2019
Same author

Editorial: hepatocellular carcinoma as a consequence of hepatitis C direct-acting anti-virals-the great urban myth of hepatology.

Alimentary pharmacology & therapeutics·2018
Same author

Editorial: hepatitis C direct acting anti-viral agents and the kidney.

Alimentary pharmacology & therapeutics·2017
Same author

Shift in disparities in hepatitis C treatment from interferon to DAA era: A population-based cohort study.

Journal of viral hepatitis·2017
Same author

Trends in health care utilization and costs attributable to hepatocellular carcinoma, 2002-2009: a population-based cohort study.

Current oncology (Toronto, Ont.)·2016

Area of Science:

  • Virology
  • Hepatology
  • Infectious Diseases

Background:

  • Seneca Valley Virus (SEN-V) is a novel single-stranded DNA virus, related to TT virus.
  • Eight genotypes (SEN-V: A-H) have been identified, with potential genotype combinations suggested.
  • SEN-V exhibits worldwide distribution, transmitted parenterally and via blood transfusions.

Purpose of the Study:

  • To investigate the association between SEN-V genotypes (specifically D and H) and post-transfusion non-A, non-E hepatitis (NANE).
  • To evaluate the role of SEN-V in various liver diseases, including acute/chronic liver disease, hepatoma, and post-transplant abnormalities.
  • To determine the efficacy of interferon-based therapy for SEN-V infections.

Main Methods:

  • Review of existing literature and case studies on SEN-V.
  • Analysis of prevalence data comparing SEN-V in patients with and without liver disease.
  • Assessment of temporal relationships between SEN-V infection and hepatitis development.

Main Results:

  • A subset of studies indicated a temporal link between SEN-V infection and NANE hepatitis, with a high association in small case clusters.
  • However, the majority of SEN-V infected individuals do not develop hepatitis.
  • Other studies found no significant difference in SEN-V prevalence across various liver conditions and controls.

Conclusions:

  • There is no definitive consensus that SEN-V is a direct cause of liver disease.
  • Despite the lack of etiological confirmation, SEN-V infections appear to respond to interferon therapy.
  • Further research is needed to clarify the pathogenic role of SEN-V and its clinical significance.

Related Experiment Videos